Patent Assignment
Reel/Frame 044133/0835
Assignment of Assignor's Interest
Recorded: 2017-11-15
Pages: 7
Assignor
INHIBRX BIOPHARMA, LLC
Executed: 2017-11-08
Assignee
INHIBRX LP
11099 N. TORREY PINES ROAD, SUITE 280, LA JOLLA, CALIFORNIA, 92037
Covered Properties
(2)
Non-Immunogenic Single Domain Antibodies
Patent:
10,526,397 →
Application:
15/003,234 →
Publication:
US 2016/0207981
PCT:
PCT/US2016/014296 ↗
Non-Immunogenic Single Domain Antibodies
Application:
62/106,035 →
Related Assignments
(12)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 2, 2015
From: ECKELMAN, BRENDAN P.; TIMMER, JOHN C.; DEVERAUX, QUINN
To: INHIBRX BIOPHARMA, LLC
Reel/Frame 035974/0879 →
Corrective Assignment to Correct the Assignee's Name Previously Recorded at Reel: 035974 Frame: 0879. Assignor(S) Hereby Confirms the Assignment.
Jul 7, 2015
From: ECKELMAN, BRENDAN P.; TIMMER, JOHN C.; DEVERAUX, QUINN
To: INHIBRX BIOPHARMA LLC
Reel/Frame 036074/0533 →
Assignment of Assignor's Interest
Apr 14, 2016
From: ECKELMAN, BRENDAN P.; TIMMER, JOHN C.; DEVERAUX, QUINN
To: INHIBRX LP
Reel/Frame 038281/0055 →
Merger and Change of Name
May 22, 2018
From: INHIBRX LP; TENIUM THERAPEUTICS, INC.
To: INHIBRX, INC.
Reel/Frame 046215/0084 →
Intellectual Property Security Agreement
Feb 28, 2022
From: INHIBRX, INC.
To: OXFORD FINANCE LLC
Reel/Frame 059262/0780 →
Assignment of Assignor's Interest
May 23, 2024
From: INHIBRX, LP
To: INHIBRX, INC.
Reel/Frame 067508/0149 →
Assignment of Assignor's Interest
May 23, 2024
From: INHIBRX BIOPHARMA, LLC
To: INHIBRX, LP
Reel/Frame 067508/0157 →
Release of Security Interest
Jun 3, 2024
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT
To: INHIBRX, INC.
Reel/Frame 067606/0247 →
Assignment of Assignor's Interest
Jun 10, 2024
From: INHIBRX, INC.
To: INHIBRX BIOSCIENCES, INC.
Reel/Frame 067680/0831 →
Assignment of Assignor's Interest
Jun 10, 2024
From: INHIBRX, INC.
To: INHIBRX BIOSCIENCES, INC.
Reel/Frame 067680/0770 →
Correction by Declaration Erroneously Filed Against Reel 038281/Frame 0055.
Jun 24, 2024
From: INHIBRX, LP
To: INHIBRX, LP
Reel/Frame 068309/0664 →
Security Interest
Jan 14, 2025
From: INHIBRX BIOSCIENCES, INC.
To: OXFORD FINANCE LLC; OXFORD FINANCE LLC
Reel/Frame 069894/0045 →